Visual Universitätsmedizin Mainz

Publikationen unter Mitarbeit des klinischen Studienzentrums

Bourne R, Kaarniranta K, Lorenz K, Traverso C, Vuorinen J, Ropo A. Changes in ocular signs and symptomsin patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study. BMJ Open. 2019 April

 

 

 

Melzer C, Ziemssen F, Eter N, Brinkmann C, Agostini H, Haeusser-Fruh G, Rose U, Schargus M, Lorenz K, Holz FG, Schmitz-Valckenberg S. Design and Baseline Characteristics of the HELP Study: An Extended and Long-Term Observation of Pathological Myopia in Caucasians. Ophthalmologica. 2018 Jun 15:1-12. doi: 10.1159/000489180.

 

 

 

Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmol. 2018 Apr 25. doi: 10.1111/aos.13771.

 

  

 

Bonini S, Lambiase A, Rama P, Filatori I, Allegretti M, Chao W, Mantelli F; REPARO Study Group. Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018 Sep;125(9):1468-1471. doi: 10.1016/j.ophtha.2018.03.004. Epub 2018 Apr 10

 

 

 

Bonini S, Lambiase A, Rama P, Sinigaglia F, Allegretti M, Chao W, Mantelli F; REPARO Study Group. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. Ophthalmology. 2018 Sep;125(9):1332-1343. doi: 10.1016/j.ophtha.2018.02.022. Epub 2018 Apr 10.

 

  

 

Pfeiffer N, Voykov B, Renieri G, Bell K, Richter P, Weigel M, Thieme H, Wilhelm B, Lorenz K, Feindor M, Wosikowski K, Janicot M, Päckert D, Römmich R, Mala C, Fettes P, Leo E. First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery. PLoS One. 2017 Nov 30;12(11):e0188899. doi: 10.1371/journal.pone.0188899. eCollection 2017

 

 

 

Wasielica-Poslednik J, Schmeisser J, Hoffmann EM, Weyer-Elberich V, Bell K, Lorenz K, Pfeiffer N. Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C. PLoS One. 2017 Oct 4;12(10):e0185246. doi: 10.1371/journal.pone.0185246. eCollection 2017.

 

  

 

Lorenz K, Scheller Y, Bell K, Grus F, Ponto KA, Bock F, Cursiefen C, Flach J, Gehring M, Peto T, Silva R, Tal Y, Pfeiffer N. A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. Trials. 2017 Mar 16;18(1):128. doi: 10.1186/s13063-017-1861-3.

 

 

 

Lorenz K, Wasielica-Poslednik J, Bell K, Renieri G, Keicher A, Ruckes C, Pfeiffer N, Thieme H. Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma. PLoS One. 2017 Feb 15;12(2):e0171636. doi: 10.1371/journal.pone.0171636. eCollection 2017.

 

  

 

Wasielica-Poslednik J, Politino G, Schmidtmann I, Lorenz K, Bell K, Pfeiffer N, Pitz S. Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases. PLoS One. 2017 Jan 12;12(1):e0168698. doi: 10.1371/journal.pone.0168698. eCollection 2017

 

 

 

Lorenz K, Beck S, Keilani MM, Wasielica-Poslednik J, Pfeiffer N, Grus FH. Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage. PLoS One. 2016 Dec 28;11(12):e0166813. doi: 10.1371/journal.pone.0166813. eCollection 2016.

 

  

 

Funke S, Beck S, Lorenz K, Kotterer M, Wolters D, Perumal N, Pfeiffer N, Grus FH. Analysis of the effects of preservative-free tafluprost on the tear proteome. Am J Transl Res. 2016 Oct 15;8(10):4025-4039. eCollection 2016

 

 

 

Lorenz K, Beck S, Keilani MM, Wasielica-Poslednik J, Pfeiffer N, Grus FH. Course of serum autoantibodies in patients after acute angle-closure glaucoma attack. Clin Exp Ophthalmol. 2017 Apr;45(3):280-287. doi: 10.1111/ceo.12864. Epub 2017 Feb 6.

 

  

 

Elflein HM, Rudy M, Lorenz K, Ponto KA, Scheurich A, Pitz S. Charles Bonnet's syndrome: not only a condition of the elderly. Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1637-42. doi: 10.1007/s00417-016-3387-x. Epub 2016 Jun 25.

 

 

 

Jongenelen S, Rozema JJ, Tassignon MJ; EVICR.net and Project Gullstrand Study Group. Distribution of the Crystalline Lens Power In Vivo as a Function of Age. Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7029-35. doi: 10.1167/iovs.15-18047.

 

  

 

Mirshahi A, Raak P, Ponto K, Stoffelns B, Lorenz K, Scharioth GB. Deep Sclerectomy with Goniosynechiolysis Ab Interno for Chronic Glaucoma Associated with Peripheral Anterior Synechiae. J Ophthalmol. 2015;2015:625719. doi: 10.1155/2015/625719. Epub 2015 Jun 23.

 

 

 

Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, Larrosa JM, Fea A, Lemij H, Gandolfi S, Schwenn O, Lorenz K, Samuelson TW. A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma. Ophthalmology. 2015 Jul;122(7):1283-93. doi: 10.1016/j.ophtha.2015.03.031. Epub 2015 May 9.

 

 

 

Pfeiffer N, Traverso CE, Lorenz K, Saarela V, Liinamaa J, Uusitalo H, Astakhov Y, Boiko E, Ropo A; Preservative-free Tafluprost/Timolol Fixed Combination Study Group. A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components. Adv Ther. 2014 Dec;31(12):1228-46. doi: 10.1007/s12325-014-0163-3. Epub 2014 Dec 2.

 

  

 

Böhringer D, Ihorst G, Grotejohann B, Maurer J, Spierings E, Reinhard T; FANCY study group. Functional antigen matching in corneal transplantation: matching for the HLA-A, -B and -DRB1 antigens (FANCY) - study protocol. BMC Ophthalmol. 2014 Dec 13;14:156. doi: 10.1186/1471-2415-14-156.

 

 

 

Lorenz K, Pfeiffer N. Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma. Expert Opin Pharmacother 2014 Oct;15(15):2255-62. doi: 10.1517/14656566.2014.955471. Epub 2014 Aug 29.

 

  

 

Lorenz K, Pfeiffer N. Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma. Expert Opin Pharmacother. 2014 Oct;15(15):2255-62. doi: 10.1517/14656566.2014.955471. Epub 2014 Aug 29. Review. Erratum in: Expert Opin Pharmacother. 2014 Nov;15(16):2473.

 

 

 

Pielen A, Mirshahi A, Feltgen N, Lorenz K, Korb C, Junker B, Schaefer C, Zwiener I, Hattenbach LO; the RABAMES Study Group. Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial. Acta Ophthalmol. 2014 Jul 8. doi: 10.1111/aos.12488. [Epub ahead of print]

 

 

 

Elflein HM, Pfeiffer N, Hoffmann EM, Hoehn R, Kottler U, Lorenz K, Zwiener I, Wild PS, Mirshahi A. Correlations between central corneal thickness and general anthropometric characteristics and cardiovascular parameters in a large European cohort from the Gutenberg Health Study. Cornea. 2014 Apr;33(4):359-65. doi: 10.1097/ICO.0000000000000068.

 

  

 

Rozema JJ, Tassignon MJ; for EVICR.net, Project Gullstrand Study Group. The bigaussian nature of ocular biometry. Optom Vis Sci. 2014 Jul;91(7):713-22. doi: 10.1097/OPX.0000000000000296.

 

 

 

Gramlich OW, Lorenz K, Grus FH, Kriechbaum M, Ehrlich D, Humpel C, Fischer-Colbrie R, Bechrakis NE, Troger J. Catestatin-like immunoreactivity in the rat eye. Neuropeptides. 2014 Feb;48(1):7-13. doi: 10.1016/j.npep.2013.11.003. Epub 2013 Nov 25.

 

  

 

Korb C, Zwiener I, Lorenz K, Mirshahi A, Pfeiffer N, Stoffelns B. Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration--evaluation in a clinical setting. BMC Ophthalmol. 2013 Dec 20;13:84. doi: 10.1186/1471-2415-13-84.

 

 

 

Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, Lorenz K, Honda M, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group. Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study. Ophthalmology. 2013 Sep 28. doi:pii: S0161-6420(13)00730-6. 10.1016/j.ophtha.2013.08.012. [Epub ahead of print]

 

  

 

Lorenz K, Dick HB, Grus F, Vetter JM, Stoffelns B, Schoepfer K, Korb C, Pfeiffer N. Series of fibrinous inflammation after implantation of capsular tension ring. J Cataract Refract Surg. 2014 Feb;40(2):192-8. doi: 10.1016/j.jcrs.2013.07.041. Epub 2013 Dec 13.

 

 

 

Hoffmann EM, Lamparter J, Mirshahi A, Elflein H, Hoehn R, Wolfram C, Lorenz K, Adler M, Wild PS, Schulz A, Mathes B, Blettner M, Pfeiffer N. Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study. PLoS One. 2013 Aug 1;8(8):e66158. doi: 10.1371/journal.pone.0066158. Print 2013.

 

  

 

Lorenz K, Wolfram C, Breitscheidel L, Shlaen M, Verboven Y, Pfeiffer N. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany. Graefes Arch Clin Exp Ophthalmol. 2013 Apr 30. [Epub ahead of print]

 

 

 

Wolfram C, Lorenz K, Breitscheidel L, Verboven Y, Pfeiffer N. Health- and Vision-related Quality of Life in Patients with Ocular Hypertension or Primary Open-angle Glaucoma. Ophthalmologica. 2013;229:227-34. doi: 10.1159/000350553. Epub 2013 Apr 24.

 

  

 

Lorenz K, Kramann C, Rauch N, Vetter JM, Elflein H, Keilani MM, Pfeiffer N. Evaluation of SENSIMED Triggerfish® 24-Hour monitoring in healthy subjects and glaucoma patients. J Glaucoma. 2013 Mar 20. [Epub ahead of print].

 

 

 

Lorenz K, Gramlich OW, Grus FH, Ehrlich D, Humpel C, Nogalo M, Fischer-Colbrie R, Bechrakis NE, Hattmannstorfer R, Troger J. GE-25-like immunoreactivity in the rat eye. Peptides. 2012 Aug;36(2):286-91. doi: 10.1016/j.peptides.2012.04.022. Epub 2012 May 23.

 

  

 

Mirshahi A, Hoehn R, Lorenz K, Kramann C, Baatz H. Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts. J Ophthalmic Vis Res. 2012 Jan;7(1):39-44.

 

 

 

Lorenz K, Rosbach K, Matt A, Pfeiffer N. Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension. Clin Ophthalmol. 2011;5:1745-50. Epub 2011 Dec 9.

 

  

 

Vetter JM, Schirra A, Garcia-Bardon D, Lorenz K, Weingärtner WE, Sekundo W. Comparison of intraocular pressure during corneal flap preparation between a femtosecond laser and a mechanical microkeratome in porcine eyes. Cornea. 2011 Oct;30(10):1150-4.

 

 

 

Vetter JM, Tubic-Grozdanis M, Faust M, Lorenz K, Gericke A, Stoffelns BM. Effect of various compositions of riboflavin eye drops on the intraoperative corneal thickness during UVA-cross-linking in keratoconus eyes. Klin Monbl Augenheilkd. 2011 Jun;228(6):509-14. Epub 2011 Jun 7. German.

 

 

 

Mirshahi A, Lorenz K, Kramann C, Stoffelns B, Hattenbach LO. Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions.] Ophthalmologe. 2011 Feb;108(2):111-116. German.

 

 

 

Lorenz K, Troger J, Gramlich O, Grus F, Hattmannstorfer R, Fischer-Colbrie R, Joachim S, Schmid E, Teuchner B, Haas G, Bechrakis N. PE11, a peptide derived from chromogranin B, in the rat eye. Peptides. 2011 Jun;32(6):1201-6. Epub 2011 Mar 23.

 

  

 

Renieri G, Führer K, Scheithe K, Lorenz K, Pfeiffer N, Thieme H. Efficacy and Tolerability of Preservative-Free Eye Drops Containing a Fixed Combination of Dorzolamide and Timolol in Glaucoma Patients. J Ocul Pharmacol Ther. 2010 Oct 26.

 

 

 

Lorenz K, Zwiener I, Mirshahi A. Subconjunctival Reflux and Need for Paracentesis after Intravitreal Injection of 0.1 ml Bevacizumab: Comparison between 27 gauge and 30 gauge Needle. Graefes Arch Clin Exp Ophthalmol. 2010.

 

  

 

Kramann C, Boehm N, Lorenz K, Wehrwein N, Stoffelns BM, Pfeiffer N, Grus FH. Effect of contact lenses on the protein composition in tear film: a ProteinChip study. Graefes Arch Clin Exp Ophthalmol. 2010 Jul 26.

 

 

 

Kramann CA, Schöpfer K, Lorenz K, Zwiener I, Stoffelns BM, Pfeiffer N. Intravitreal ranibizumab treatment of retinal angiomatous proliferation. Acta Ophthalmol. 2010 Jun 24.

 

  

 

Mirshahi A, Hoehn F, Lorenz K, Hattenbach LO. Incidence of Posterior Vitreous Detachment after Cataract Surgery. J Cataract Refract Surg. 2009 Jun;35(6):987-91.

 

 

 

Lorenz K, Troger J, Fischer-Colbrie R, Kremser B, Schmid E, Kralinger M, Teuchner B, Bechrakis N, Kieselbach G. Substance P and Secretoneurin in vitreous aspirates of patients with various vitreoretinal diseases. Peptides. 2008 Sep;29(9):1561-5. Epub 2008 May 4.

 

 

 

Lorenz K, Dick B, Jehkul A, Auffahrt GU. Inflammatory response after endocapsular phacoemulsification treated with 0.5% prednisolone acetate or vehicle. Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1617-22. Epub 2008 Aug 26.

 

 

The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
“Reproducibility of evaluation of optic disc change with stereo optic disc photographs.”
Ophthalmology 2003; 110, 2: 340-44

 

 

 

A. Vogel(1), I. Kersten-Gomez(1), R. Troost(2), S. Pourjavan(3), G. Bertoni(4), S. Gandolfi(5), T. Zeyen(6), S. Miglior(7), N. Pfeiffer(1) and The European Glaucoma Prevention Study Group
"Central corneal thickness in a subgroup of the European Glaucoma Prevention Study." Association of Research in Vision and Ophthalmology, Fort Lauderdale 2003
1 Department of Ophthalmology, Johannes Gutenberg-University Mainz, Germany       2 Coordination Center for Clinical Trials, Johannes Gutenberg-University Mainz, Germany
3 Department of Ophthalmology, Leuven, Belgium      4 Department of Opthalmology, Milano, Italy      5 Department of Opthalmology, Parma, Italy
6 Department of Opthalmology, Middelheim Hospital, Belgium      7 Department of Ophthalmology, Clinica Oculistica Universita di Milano, Milano, Italy

 

 

 

N. Pfeiffer(1) ,A. Vogel(1), I. Kersten-Gomez(1), R. Troost(2), T. Zeyen(3) and The European Glaucoma Prevention Study Group
"Longitudinal evaluation of central corneal thickness in ocular hypertensive patients."
Association of Research in Vision and Ophthalmology, Fort Lauderdale 2003
1 Department of Ophthalmology, Johannes Gutenberg-University Mainz, Germany      2 Coordination Center for Clinical Trials, Johannes Gutenberg-University Mainz, Germany
3 Department of Opthalmology, Middelheim Hospital, Belgium

 

 

 

Traverso CE, Gandolfi SA, Kelly SP, Hommer AH, Renard J-P, Nordmann J-P, Bron AM, Denis P, Pfeiffer N, Bayer A, Grehn FJ, Orzalesi N, Cedrone C, Salmon J,Augusto A-B, Hitchings R, Walt JG, Buchholz PM, Kotak SV, Siegartel LE, Rosenblatt LC, Cuccia AJ, Doyle JJ
"Estimation of Resource Utiliziation Associated with Glaucoma Disease progression in a multi-national retrospective study in Europe."
Association of Research in Vision and Ophthalmology, Fort Lauderdale 2003

 

 

 

The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.)).
"The European Glaucoma Prevention Study design and baseline description of the participants.”
Ophthalmology 2002; 109, 9: 1612-1621

 

 

 

A. Vogel, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
„European Glaucoma Prevention Study (EGPS)“
100. Tagung der Deutschen Ophthalmologischen Gesellschaft, Berlin 2002; Ophthalmologe 2002; 99, Suppl. 1: S118

 

 

 

S.H. Yun, A. Jünemann, G. Karasheva, M. Küchle, O. Schwenn, D. Spiegel, A. Vogel, I. Wimmer, F. Grehn
“CAT-152-Studie bei fistulierender Operation”
100. Tagung der Deutschen Ophthalmologischen Gesellschaft, Berlin 2002; Ophthalmologe 99, Suppl. 1: S117

 

 

 

R. Troost, A. Vogel, M. Wagner, O. Schwenn
“Entwicklung eines klinischen Datenbanksystems für Glaukomerkrankungen auf einer Remote Data Entry Platform”
100. Tagung der Deutschen Ophthalmologischen Gesellschaft, Berlin 2002, Ophthalmologe 99, Suppl.1: S173

 

 

 

A. Vogel, R. Troost, R. Yun, O. Schwenn, O. Schwenn, N. Pfeiffer
„Datenmodell einer Glaukomdatenbank für eine Universitätsaugenklinik“
100. Tagung der Deutschen Ophthalmologischen Gesellschaft, Berlin 2002, Ophthalmologe 99, Suppl. 1: S165

 

 

 

I.Kersten, A.Vogel, S.Kaiser, U.Luka-Krausgrill, N. Pfeiffer, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
„Compliance in prevention of glaucoma: an evaluation in the EGPS“
Association of Research in Vision and Ophthalmology, Fort Lauderdale 2001; Invest Ophthalmol Vis Sci 2001; 42: 819

 

 

 

A. Vogel, S. Kaiser, U. Krausgrill, I. Kersten, N. Pfeiffer, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
„Compliance bei der Prävention einer chronischen Erkrankung: Evaluation im Rahmen der European Glaucoma Prevention Study (EGPS)“
99. Tagung der DOG 29.9.-2-10.2001

 

  

 

Zeyen TG, Linsen MC, Fabre K, D’hondt K, Michiels I, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
“Reproducibility of serial optic disc stereo slides evaluation by experienced ophthalmologists, last year residents, and in ophthalmic photographer.”
Association of Research in Vision and Ophthalmology, Fort Lauderdale 2000; Invest Ophthalmol Vis Sci, 41 (4): S289

 

 

 

Miglior S, Pfeiffer N, Cunha-Vaz J, Zeyen T, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
“The European Glaucoma Prevention Study: Baseline Description of the Participants.”
Association of Research in Vision and Ophthalmology, Fort Lauderdale 2000; Invest Ophthalmol Vis Sci 2000, 41 (4): S517

 

 

 

A.Vogel, I.Kersten, S. Kaiser, U. Luka-Krausgrill, N. Pfeiffer, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
„Compliance in prevention of a chronic disease: a national evaluation in the European Glaucoma Prevention Study (EGPS)“
13. Kongreß der Society of Ophthalmology in Europe 2000, Istanbul, Abstractbuch

 

 

 

Zeyen TG, Miglior S, Pfeiffer N, Cunha-Vaz J, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
“The European Glaucoma Prevention Study: reproducibility of serial optic disc stereo slides evaluation.”
Association of Research in Vision and Ophthalmology, Fort Lauderdale 1999; Invest Ophthalmol Vis Sci 1999, 40: S396

 

 

 

Miglior S, Pfeiffer N, Cunha-Vaz J, Zeyen T, The European Glaucoma Prevention Study Group (Clinical Centers Germany: University of Mainz (u.a.); Optic Disc Readers: University of Mainz (u.a.))
“The European Glaucoma Prevention Study: objectivs and methods.”
Association of Research in Vision and Ophthalmology, Fort Lauderdale 1999; Invest Ophthalmol Vis Sci 1999, 40: S566